• Simon de Denus, Nathalie Letarte, Thierry Hurlimann, Jean-Philippe Lambert, Annie Lavoie, Laura Robb, Nancy L Sheehan, Jacques Turgeon, and Barbara Vadnais.
• Université de Montréal, Montreal, Canada. simon.dedenus@icm-mhi.org
• Pharmacogenomics. 2013 Jan 1; 14 (2): 165-75.

BackgroundGiven their expertise in pharmacotherapy, pharmacists are well positioned to play a leading role in the implementation of pharmacogenomics in clinical practice. However, little is known about the opinions of pharmacists towards pharmacogenomics or their willingness to integrate this new field in their practice.MethodsWe conducted a survey of 284 pharmacists practicing in the province of Québec (Canada) to describe the opinions, expectations and concerns of pharmacists toward pharmacogenomics.ResultsPharmacists were very hopeful regarding the potential role of pharmacogenomics. Moreover, more than 95% of responders would be willing to recommend pharmacogenomic testing. Nevertheless, only 7.7% of pharmacists currently felt comfortable advising patients based on pharmacogenomic test results. Accordingly, the majority of responders (96.6%) indicated that they would like to undertake continuing education related to pharmacogenomics.ConclusionPharmacists are extremely hopeful towards pharmacogenomic testing. Furthermore, a vast majority is willing to integrate these tests as part of their clinical practice. Proper education will be required if the integration of pharmacogenomics in patient care is to be optimal.

12 keywords...

hide…